Preparing for CAR-T Therapy: Key Considerations and Timing in Multiple Myeloma Treatment

Opinion
Video

Panelists discuss the key considerations in preparing patients for chimeric antigen receptor (CAR) T-cell therapy and how the treatment process differs when CAR T-cell therapy is used in earlier vs later stages of multiple myeloma.

Video content above is prompted by the following:

  • What are the key considerations in preparing patients for chimeric antigen receptor (CAR) T-cell therapy?
  • How does the treatment process differ when CAR T-cell therapy is used earlier compared with later stages of multiple myeloma?
Recent Videos
3 experts are featured in this series.
6 experts are featured in this series.
Related Content